Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Raman

Showing results (441-450 of 455) with videos related to

Pageof 46
Sort By:
Urologic Oncology|December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
Cancers|March 11, 2023
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched AnalysisNico C Grossmann, Francesco Soria, Tristan Juvet, et al.
The Journal of Urology|January 5, 2022
Reply by AuthorsSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
The Journal of Urology|December 17, 2021
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final ReportSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
World Journal of Urology|July 23, 2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinomaLuca Afferi, Benjamin Pradere, Andrea Gallioli, et al.
Cancers|April 12, 2022
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care MetricsFrederik König, Nico C Grossmann, Francesco Soria, et al.
European Urology|January 31, 2012
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinomaEugene K Cha, Shahrokh F Shariat, Matthias Kormaksson, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
Journal of Robotic Surgery|October 14, 2024
The impact of single-port robotic surgery: a survey among urology residents and fellows in the United StatesEugenio Bologna, Leslie Claire Licari, Ketan K Badani, et al.
Pageof 46

Showing results (441-450 of 455) with videos related to

Sort By:
Pageof 46
Urologic Oncology|December 22, 2019
PTRF independently predicts progression and survival in multiracial upper tract urothelial carcinoma following radical nephroureterectomyHsin-Chih Yeh, Vitaly Margulis, Nirmish Singla, et al.
European Urology Oncology|January 23, 2024
Oncologic Outcomes in Patients with Residual Upper Tract Urothelial Carcinoma Following Neoadjuvant ChemotherapySean A Fletcher, Maximilian Pallauf, Emelia K Watts, et al.
Cancers|March 11, 2023
Comparing Oncological and Perioperative Outcomes of Open versus Laparoscopic versus Robotic Radical Nephroureterectomy for the Treatment of Upper Tract Urothelial Carcinoma: A Multicenter, Multinational, Propensity Score-Matched AnalysisNico C Grossmann, Francesco Soria, Tristan Juvet, et al.
The Journal of Urology|January 5, 2022
Reply by AuthorsSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
The Journal of Urology|December 17, 2021
Durability of Response to Primary Chemoablation of Low-Grade Upper Tract Urothelial Carcinoma Using UGN-101, a Mitomycin-Containing Reverse Thermal Gel: OLYMPUS Trial Final ReportSurena F Matin, Phillip M Pierorazio, Nir Kleinmann, et al.
World Journal of Urology|July 23, 2025
Oncological outcomes of open versus minimally invasive nephroureterectomy for locally advanced upper tract urothelial carcinomaLuca Afferi, Benjamin Pradere, Andrea Gallioli, et al.
Cancers|April 12, 2022
Pentafecta for Radical Nephroureterectomy in Patients with High-Risk Upper Tract Urothelial Carcinoma: A Proposal for Standardization of Quality Care MetricsFrederik König, Nico C Grossmann, Francesco Soria, et al.
European Urology|January 31, 2012
Predicting clinical outcomes after radical nephroureterectomy for upper tract urothelial carcinomaEugene K Cha, Shahrokh F Shariat, Matthias Kormaksson, et al.
The Lancet. Oncology|July 8, 2020
Primary chemoablation of low-grade upper tract urothelial carcinoma using UGN-101, a mitomycin-containing reverse thermal gel (OLYMPUS): an open-label, single-arm, phase 3 trialNir Kleinmann, Surena F Matin, Phillip M Pierorazio, et al.
Journal of Robotic Surgery|October 14, 2024
The impact of single-port robotic surgery: a survey among urology residents and fellows in the United StatesEugenio Bologna, Leslie Claire Licari, Ketan K Badani, et al.
Pageof 46